[ Price : $8.95]
Precision BioScience says it will meet with FDA in June to discuss a regulatory way forward through a Phase 2 trial for its azer-c...[ Price : $8.95]
Sixteen advocacy organizations urge FDA to regulate laboratory-developed tests if Congress fails to produce a strong bill.[ Price : $8.95]
FDA completes a previously delayed pre-licensing inspection of China-based Shanghai Junshi Biosciences breakthrough cancer drug to...[ Price : $8.95]
FDA and the European Union agree to expand the scope of the U.S.-EU mutual recognition agreement to include inspections of veterin...[ Price : $8.95]
FDA says that beginning 6/12 it will expand in-person industry meetings to include requests for Type B End-of-Phase 2 requests at ...[ Price : $8.95]
FDA proposes a regulation to replace the current Medication Guides with a one-page Patient Medication Information sheet.[ Price : $8.95]
FDA warns Woburn, MA-based Advanced Compounding Solutions about multiple violations in its production of unapproved and misbranded...[ Price : $8.95]
FDA accepts for priority review a Bristol Myers Squibb NDA for repotrectinib and its use for treating patients with ROS1-positive ...